000 01419 a2200409 4500
005 20250515135243.0
264 0 _c20090508
008 200905s 0 0 eng d
022 _a1545-7206
024 7 _a10.1176/appi.psy.49.5.442
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchaefer, Martin
245 0 0 _aThree cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders.
_h[electronic resource]
260 _bPsychosomatics
_c
300 _a442-6 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAntidepressive Agents, Second-Generation
_xtherapeutic use
650 0 4 _aAntiviral Agents
_xadverse effects
650 0 4 _aDepressive Disorder, Major
_xchemically induced
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTryptophan
_xtherapeutic use
700 1 _aWinterer, Jochen
700 1 _aSarkar, Rahul
700 1 _aUebelhack, Ralf
700 1 _aFranke, Leonora
700 1 _aHeinz, Andreas
700 1 _aFriebe, Astrid
773 0 _tPsychosomatics
_gvol. 49
_gno. 5
_gp. 442-6
856 4 0 _uhttps://doi.org/10.1176/appi.psy.49.5.442
_zAvailable from publisher's website
999 _c18262869
_d18262869